… ) for long SFA lesions remains poor [3, 4]. Primary stent placement in long SFA lesions has
… However, in bare-metal stents (BMS) the risk of in-stent restenosis and stent fracture grows …

… the ZILVER® PTXTM stent is being evaluated in the AK FP vasculature for lesions up to 28
… who will have received the paclitaxel coated ZILVER® stents for FF lesions. At the 2007 …

… to investigate the impact of nitinol stenting of SFA lesions with a maximum length of 10 cm
… and Proximal Popliteal Artery Lesions) study, an everolimus-coated stent is being evaluated …

… stenting strategies with versus without stent coverage of the SFA ostium and the DFA origin
in patients with SFA lesions … was successfully treated with a covered stent. There were no …

… stent margins or between the struts may limit the efficacy especially in the SFA due to larger
stent … deliver an antiproliferative drug at the site of injury has become one of the most inter…

… As such, in-depth discussion has not been included in this article and will be covered …
registry that allowed inclusion of longer lesions, instent restenosis, and lesions as far distal as the …

… of lesion and clinical symptoms influence negatively the patency. The aSpire covered stent
… in the treatment of SFA lesions is still controversial, and the use of stents has not given …

… least 120 s with a paclitaxel-coated balloon (In.Pact Admiral, … , included lesions positioned
at the stent body, the stent edge… not only stent body lesions, but also stent edge lesions; and …

… lesions up to 15 cm. The use of CS has improved the short-term patency in our series with
SFA lesions … when CS is used for a variety of lesion lengths. Fischer et al 14 reported primary …

… from a registry comparing paclitaxel-eluting stents with PCBs in long lesions, with a mean
lesion length of 19 cm in both groups. Primary paclitaxel-eluting stenting was associated with a …